Literature DB >> 28680028

Associaton of elevated troponin levels with increased heart rate and higher frequency of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy.

Rafał Hładij, Renata Rajtar-Salwa, Paweł Petkow Dimitrow.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28680028     DOI： 10.20452/pamw.4053

Source DB:  PubMed          Journal:  Pol Arch Intern Med        ISSN： 0032-3772


× No keyword cloud information.
  6 in total

1.  Elevated Level of Troponin but Not N-Terminal Probrain Natriuretic Peptide Is Associated with Increased Risk of Sudden Cardiac Death in Hypertrophic Cardiomyopathy Calculated According to the ESC Guidelines 2014.

Authors:  Renata Rajtar-Salwa; Rafał Hładij; Paweł Petkow Dimitrow
Journal:  Dis Markers       Date:  2017-11-20       Impact factor: 3.434

2.  Serum N-terminal pro-B-type natriuretic peptide levels are associated with left atrial dilation, resting left ventricular outflow tract gradient, and pulmonary hypertension in patients with hypertrophic cardiomyopathy.

Authors:  Adam Gębka; Renata Rajtar-Salwa; Artur Dziewierz; Paweł Petkow-Dimitrow
Journal:  Postepy Kardiol Interwencyjnej       Date:  2020-02-09       Impact factor: 1.426

3.  Troponin as ischemic biomarker is related with all three echocardiographic risk factors for sudden death in hypertrophic cardiomyopathy (ESC Guidelines 2014).

Authors:  Rafał Hładij; Renata Rajtar-Salwa; Paweł Petkow Dimitrow
Journal:  Cardiovasc Ultrasound       Date:  2017-09-13       Impact factor: 2.062

4.  Anginal pain and elevated troponin level despite normal coronary angiography: hypertrophic cardiomyopathy with severe obstruction due to vasodilator/diuretic therapy for coincident arterial hypertension.

Authors:  Adam Gębka; Renata Rajtar-Salwa; Rafał Hładij; Paweł Petkow Dimitrow
Journal:  Postepy Kardiol Interwencyjnej       Date:  2018-03-22       Impact factor: 1.426

5.  Painful and painless myocardial ischemia detected by elevated level of high-sensitive troponin in patients with hypertrophic cardiomyopathy.

Authors:  Adam Gębka; Renata Rajtar-Salwa; Artur Dziewierz; Paweł Petkow-Dimitrow
Journal:  Postepy Kardiol Interwencyjnej       Date:  2018-06-19       Impact factor: 1.426

6.  Correlations between cardiac troponin I and nonsustained ventricular tachycardia in hypertrophic obstructive cardiomyopathy.

Authors:  Limin Liu; Shangyu Liu; Lishui Shen; Bin Tu; Zhicheng Hu; Feng Hu; Lihui Zheng; Ligang Ding; Xiaohan Fan; Yan Yao
Journal:  Clin Cardiol       Date:  2020-08-18       Impact factor: 2.882
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.